Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models

Molecular Therapy - Oncolytics - United Kingdom
doi 10.1016/j.omto.2017.08.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy

Cancer immunology research
Cancer ResearchImmunology
2018English

Oncolytic Potency and Reduced Virus Tumor-Specificity in Oncolytic Virotherapy. A Mathematical Modelling Approach

PLoS ONE
Multidisciplinary
2017English

Investigation of the Vesicular Stomatitis Virus Matrix Protein: Uncoating and Assembly

English

Oncolytic Virotherapy

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Density-Dependent Selection in Vesicular Stomatitis Virus

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2004English

A GP64-Null Baculovirus Pseudotyped With Vesicular Stomatitis Virus G Protein

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

P3.01-83 Use of Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus in Preclinical Models of NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Mechanism of Membrane Fusion Induced by Vesicular Stomatitis Virus G Protein

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2016English

Improved Oncolytic Virotherapy by Increasing Virus Spread Within Tumors.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy